Access TOC
Download Data
December 2024
The global medical biomimetics market size is calculated at USD 35.85 billion in 2024, grew to USD 38.59 billion in 2025, and is projected to reach around USD 74.87 billion by 2034. The market is expanding at a CAGR of 7.64% between 2025 and 2034. The rising incidences of chronic disorders, technological advancements, and growing research and development activities drive the market.
Unlock Infinite Advantages: Subscribe to Annual Membership
Biomimetics is a process of creating man-made materials inspired by nature to develop novel scientific, technical, and technological solutions suitable for interventional applications in various fields. Medical biomimetics combines biology and technology to develop healthcare solutions. This method involves developing composite materials that mimic the characteristics and structures of diverse materials, such as tissues or organs. In the healthcare sector, they are used in tissue engineering, regenerative medicine, drug/protein delivery, bioimaging, and biosensing. Biomaterials act as substrates that help the cell migrate and attach to various surfaces. Medical biomimetics has applications in numerous areas, including cardiovascular, ophthalmology, dentistry, and orthopedics.
The growing research and development activities to develop novel biomaterials due to the rising incidences and prevalence of chronic disorders boost the medical biomimetics market. The rising adoption of advanced technology and rapid advancements in the biomedical field increase the demand for medical biomimetics. The increasing demand for new drug discovery, prostheses, and regenerative medicine also potentiates market growth. The burgeoning medical device sector and the biotechnology sector promote the development of biomaterials using medical biomimetics.
Artificial intelligence (AI) can revolutionize the biomimetics field, leading to novel innovations and overcoming conventional challenges. AI can aid in transforming the research process related to preparing biomaterials. Deep learning (DL) algorithms possess robust learning and design ability, which helps develop computer-aided drug designs. This can further assist in designing novel biomaterials, discovering novel drug targets, and other areas of healthcare research. AI can be used to stimulate and predict the optimal structures of biomaterials, their physicochemical properties, bioactivity, and modulatory mechanisms. AI can also streamline the entire manufacturing process involving biomaterials. It introduces consistency and reproducibility, reducing manual errors. Furthermore, AI and machine learning (ML) algorithms can predict the interaction of biomaterials with biological systems.
Demand for Nanotechnology
The demand for medical biomimetics is stimulated due to recent advancements in nanoscience and nanotechnology. Nanotechnology is in high demand owing to the rising demand for biodegradable composites globally to reduce environmental impact and increase the efficiency of industrial output. It has widespread applications in automobiles, textiles, food, agriculture, healthcare, construction, etc. sectors. However, its applications in the healthcare sector are promising, as are the latest innovations in diagnostics, treatment, screening, and disease prevention. Some common examples of nanomaterials include graphene, polymeric nanoparticles, nanogels, carbon nanotubes, metal-organic nanomaterials, and supramolecular nanostructures. Other examples of biomimetic nanotechnology are artificial enzymes and self-assembling nano-scale systems, such as highly efficient catalysts and sensors. The increasing investments and collaborations in nanotechnology also potentiate market growth.
Complexity and Intellectual Property
The major challenge of the medical biomimetics market is the complexity of the natural systems. Natural systems are complex; hence, it is difficult to understand their functionality and to imitate them in a design, restricting the design of novel biomaterials. Another major challenge of the market is the intellectual property issues. Intellectual property issues may arise due to using natural systems in design. Both these factors hinder market growth.
4D Bio-Printing
4D bio-printing is a type of 3D bio-printing that uses time as a fourth dimension to manufacture objects that change shape or function in response to external stimuli. This leads to manufacturing dynamic, shape-shifting pharmaceutical products and drug delivery systems that adapt to their environment or the patient’s needs. Integrating 4D bio-printing with medical biomimetics leads to designing and fabricating biomedical devices, such as stents, occluders, microneedles, smart 3D-cell engineered microenvironments, drug delivery systems, wound closures, and implantable medical devices. The technique provides greater flexibility and versatility as one structure can serve multiple functions. Thus, the recent applications of 4D bio-printing technology and smart materials in medical engineering can provide a better perspective on the future of 4D printing applications.
By type, the cardiovascular segment held a dominant presence in the medical biomimetics market in 2024. The major factors that govern the segment’s growth include the rising incidences and prevalence of cardiovascular disorders (CVDs) and growing research and development activities. Some common examples of biomaterials used in CVD treatment include biomimetic cardiac tissue models, exosomes, and nanocarriers. Researchers are focusing on developing novel biomaterials using nanotechnologies owing to their superior properties. Biomaterials must have considerable mechanical strength to support handling, implantation, and the functional demands of the cardiovascular system.
By type, the orthopedics segment is expected to grow at the fastest rate in the medical biomimetics market during the forecast period. The increasing number of orthopedic surgeries and the rising prevalence of orthopedic disorders boost the segment’s growth. The increasing number of occupational hazards, sports-related injuries, and road accidents account for orthopedic injuries. It is estimated that 3.7 million people globally were treated in emergency departments due to sports-related injuries in 2023. Novel biomaterials are designed using biomimetics to restore the structure, composition, and physiological functions of the natural bone tissue. Biomimetics is widely used to develop prostheses and bone implants.
By application, the wound healing segment led the global medical biomimetics market in 2024. Biomimetics is emerging as a promising approach for redirecting fibrotic wound healing into a regenerative process. Biomaterials are used to prepare scaffolds, hydrogels, impermeable films, alginates, hydrocolloids, and foams for effective wound healing. They are also employed in administering nucleic acids to chronic wounds that are non-healing. The rising prevalence of diabetes, accounting for 529 million cases in 2023, necessitates the development of biomaterials for chronic wounds.
By application, the drug delivery segment is predicted to witness significant growth in the medical biomimetics market over the forecast period. The segment’s growth is attributed to the rising incidences of chronic disorders and growing drug discovery and drug delivery research. The need for targeted and timely delivery of drugs necessitates the development of novel drug delivery systems. Technological advancements also augment the segment’s growth. The advent of 3D and 4D bioprinting technologies favors the generation of biomaterials.
North America held the largest share of the medical biomimetics market in 2024. The state-of-the-art research and development facilities, technological advancements, and the presence of key players drive the market. The key players, such as Abbott Laboratories, CellCore BioSciences, Stryker, etc., hold the major share of the market. The rising geriatric population leads to increasing incidences of chronic disorders, thereby increasing the demand for biomaterials. The US reported approximately 59.2 million people 65 years and above in 2023, while there were 7.6 million people 65 years and above in Canada in 2023. The Food and Drug Administration (FDA) regulates the approval of biomaterials in the US. The US FDA approved a total of 52 medical devices in 2023. The increasing investments and public-private partnerships in the U.S. and Canada also support the development of biomaterials using biomimetics.
Asia-Pacific is anticipated to grow at the fastest rate in the medical biomimetics market during the forecast period. The rising incidences of chronic disorders, increasing adoption of advanced technologies, and growing medical device and biotechnology sectors drive the market. Favorable government policies and increasing investments also promote market growth in Asia-Pacific. 3D printing technology is widely used in Asia-Pacific to manufacture numerous materials. China is the leading global market for 3D printing owing to favorable government support, quick technological advancement, and increasing investments. The Indian Government also released a national strategy for Additive Manufacturing to make India a global hub for the design, development, and deployment of 3D printing. The Japanese government developed a “Bioeconomic Strategy” in 2019 to achieve the world’s most advanced bioeconomy society by 2030.
Donna Bibber, Vice President of Business Development at Isometric Micro Molding, commented in her recent presentation at the BIOMEDigital conference that biomimicry is using those features or surfaces in nature that will help biomedical engineers to develop new and better medical and drug-delivery devices of the future.
By Type
By Application
By Region
December 2024
December 2024
December 2024
December 2024
Annual Access, Limitless Research! Unlock all market research reports with our annual subscription. Stay on top of market trends and crucial insights year-round!
2500+
Client Queries in 20235000+
Insights Published60+
Consulting Projects Per Year40+
Analysts